Type 2 Diabetes With Partial Lipodystrophy of the Limbs A new lipodystrophy phenotype Featured Article: Leah R. Strickland, B.S., Fangjian Guo, M.D., Kerry.

Slides:



Advertisements
Similar presentations
Assessment of Overweight and Obesity and the Need for Weight Loss Dr. David L. Gee FCSN/PE 446 Nutrition, Weight Control & Exercise.
Advertisements

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity Featured Article: Ricardo V. Cohen, M.D., Jose C. Pinheiro, M.D.,
Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin Featured Article: Beverley Balkau, Philip D. Home, Maya Vincent,
New Insulin Glargine 300 Units∙mL2-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine.
Severe Hypoglycemia and Mortality After Cardiovascular Events for Type 1 Diabetic Patients in Sweden Featured Article: Tom W.C. Lung, Dennis Petrie, William.
Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial Featured Article: Ravi Retnakaran, Caroline K.
An Automated Internet Behavioral Weight-Loss Program by Physician Referral: A Randomized Controlled Trial Featured Article: J. Graham Thomas, Tricia M.
Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive Featured Article: Carmel.
Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?
Update on Pediatric Obesity Lessons Learned Diane Dooley MD.
Oxidative Stress in Skeletal Muscle Diabetes This study was initiated to more rigorously examine insulin actions in the context of heightened state of.
A Randomized Placebo- Controlled Trial of Metformin for the Treatment of HIV Lipodystrophy Rakhi Kohli MD MS, Christine Wanke MD, Sherwood Gorbach MD,
Follow Up Questions Diabetes is caused by an increase in blood glucose. People with diabetes II also have a very high risk for developing Alzheimer’s disease.
Metabolic Effects of Bariatric Surgery
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
 GLP-1 agonists have shown to help patients lose weight  Mechanism of GLP-1 agonists  Cardioprotective effects of GLP-1 agonists  GLP-1 agonists and.
Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes Featured Article: Aris Siafarikas, F.R.A.C.P., M.D., Robert J.
Long-Term Complications and Mortality in Young-Onset Diabetes Type 2 diabetes is more hazardous and lethal than type 1 diabetes Featured Article: Maria.
Evaluation of Current Eligibility Criteria for Bariatric Surgery Diabetes prevention and risk factor changes in the Swedish Obese Subjects (SOS) study.
Surge in Newly Identified Diabetes Among Medicaid Patients in 2014 Within Medicaid Expansion States Under the Affordable Care Act Featured Article: Harvey.
Effect of 8 Weeks of Overfeeding on Ectopic Fat Deposition and Insulin Sensitivity: Testing the “Adipose Tissue Expandability” Hypothesis Featured Article:
Extra-Virgin Olive Oil Reduces Glycemic Response to a High–Glycemic Index Meal in Patients With Type 1 Diabetes: A Randomized Controlled Trial Featured.
Independent variables (baseline) Loge (HOMA-IR) b P
THE KÖBBERLING SYNDROME (TYPE 1 PARTIAL FAMILIAR LIPODYSTROPHY)
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Serum Total 25‐OH Vitamin D Adds Little Prognostic Value in Patients Undergoing Coronary Catheterization by Michael E. Gerling, Matthew T. James, Stephen.
Figure 2 Pathophysiology of hyperglycaemia in T2DM
Prediabetes Screening and Monitoring
Nat. Rev. Endocrinol. doi: /nrendo
The prevalence of diabetes (A), impaired glucose tolerance (B), impaired fasting glucose (C), and impaired glucose metabolism (D) among those with Finnish.
DiRECT (Diabetes Remission Clinical Trial)
Metabolic Flexibility in Health and Disease
Gerry H. Tan, M.D., Roger L. Nelson, M.D.  Mayo Clinic Proceedings 
Figure 3 Clinical algorithms in the management of NASH and diabetes mellitus Figure 3 | Clinical algorithms in the management of NASH and diabetes mellitus.
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Clinical aspects of LGMD subtypes
James F. List, Jean M. Whaley  Kidney International 
Dandan Wang et al. BTS 2018;3: Down-Regulation of miR-24 in Response to Insulin Infusion in Human Plasma Human plasma insulin (A), glucose (B),
Fasting plasma adiponectin concentration in relation to body mass index (BMI) (A), waist circumference (B), acute insulin response (AIR) (C) and insulin.
Metabolic Flexibility in Health and Disease
Comparison of clinical and functional parameters between the CMV+ and CMV− participants in the healthy elderly and elderly patients with T2DM. Comparison.
(A) T2DM: serum glucose levels during glucose tolerance test (n=6 per group). (A) T2DM: serum glucose levels during glucose tolerance test (n=6 per group).
Hyperinsulinemic-euglycemic clamps revealed that obese TPL2KO mice have an improved insulin sensitivity compared with obese WT mice. Hyperinsulinemic-euglycemic.
NOx ASR (in mmol/day), arginine Ra (in µmol/kg × min), the fraction of arginine flux converted to NOx (%), and the insulin-mediated glucose disposal (M)
Incidence of diabetes over time depends on GIS
TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.
Glucose infusion rate required to maintain the hyperglycemic clamp during the experimental period in sedentary and exercised dogs receiving basal or elevated.
The incidence of insulin-treated type 1 diabetes in the first 35 years of life. The incidence of insulin-treated type 1 diabetes in the first 35 years.
Statin Therapy in Patients With Insulin Resistance
Left columns: Plasma glucose and serum insulin concentrations, circulating TF-PCA, and FVIIa activity before and during 24 h of selective hyperglycemia.
Comparison of women carrying a male fetus and those carrying a female fetus, with respect to mean adjusted blood glucose levels during the OGTT (A), mean.
A: The correlation between the GIR and FGU, each measured during the last 40 min of the euglycemic insulin clamp. A: The correlation between the GIR and.
A: Mean wall motion score index (95% CI) in patients with first myocardial infarction segregated by Hp type. A: Mean wall motion score index (95% CI) in.
The underlying physiological basis of the HOMA model.
Categorical A1c distribution within BMI categories, n=414 266 patients with T2D and available A1c data. % values represent percentage of subjects within.
Mean (±SE) plasma glucose concentrations before, during, and after infusions of octreotide (with growth hormone) with saline (•), with insulin replacement.
Adjusted HRs (95% CIs) for all-cause mortality associated with body fat percentage by smoking status in men and women and by CHD, type 2 diabetes, and.
Absence of OcaB protects against age-induced insulin resistance.
ORs for presence of the metabolic syndrome (95% CI) at age 43 years according to leisure-time physical activity and TV viewing (adjusted for sex, socioeconomic.
Relationship between changes in mean fat cell volume and insulin sensitivity (M values) after gastric bypass of obese women. Relationship between changes.
Adjusted ORs for pregravid, antepartum, and postpartum factors as predictors of likelihood that a woman will gain weight between 3 and 12 months postpartum.
Diabetes in Young Adults
Spearman rank order correlation between suppression of hepatic glucose production with low insulin infusion and 30-min change in glucose response in women.
Effects of PCSK7 rs genotype and CHO diets on changes and reversion in fasting insulin levels and HOMA-IR during the 2-year intervention in white.
Risk of mortality in patients with diabetes and ESRD
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients
Twice daily regimen N=45 MDI regimen N=28 P Value
Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.
Insulin secretion (hyperglycemic clamp) (A), insulin sensitivity (hyperinsulinemic-euglycemic clamp) (B), and glucose disposition index (GDI) (C) in adolescents.
Presentation transcript:

Type 2 Diabetes With Partial Lipodystrophy of the Limbs A new lipodystrophy phenotype Featured Article: Leah R. Strickland, B.S., Fangjian Guo, M.D., Kerry Lok, M.D., W. Timothy Garvey, M.D. Diabetes Care Volume 36: August, 2013

STUDY OBJECTIVE Lipodystrophies are categorized by the extent of fat loss and by inheritance We examined whether a group of patients with partial lipodystrophy of the limbs (PLL), type 2 diabetes mellitus (T2DM), and an absence of family history of lipodystrophy constitute a new clinical subtype Strickland L. R. et al. Diabetes Care 2013;36:

STUDY DESIGN AND METHODS Ten women with T2DM and PLL were identified and matched by age, sex, BMI, ethnicity, and diabetes status with 10 women with control T2DM without PLL All patients were characterized by clinical evaluation and hyperinsulinemic clamp Strickland L. R. et al. Diabetes Care 2013;36:

RESULTS Patients with T2DM and PLL exhibited symmetrical loss of subcutaneous fat in forearms, or forearms plus calves, and acanthosis nigricans Glucose disposal rates were reduced by 56% in the T2DM with PLL group compared with the control T2DM patients Most PLL patients exhibited little or no insulin-mediated glucose uptake after subtraction of non-insulin–mediated glucose uptake The T2DM with PLL group also had greater elevations in hepatic transaminases and triglycerides and earlier onset of diabetes than the control T2DM group Strickland L. R. et al. Diabetes Care 2013;36:

CONCLUSIONS T2DM with PLL represents a previously unrecognized phenotype of lipodystrophy and T2DM These T2DM patients exhibit: Symmetrical lipodystrophy of the distal limbs Acanthosis nigricans Marked insulin resistance with little insulin-mediated glucose uptake Hypertriglyceridemia Hepatic transaminase elevations Strickland L. R. et al. Diabetes Care 2013;36: